Fitzpatrick, Cella, Harper & Scinto Law Firm Profile

More Profiles:
Choose A Law Firm

on Fitzpatrick, Cella, Harper & Scinto

  • - Financial Information
  • - Compensation
  • - Billing Rates
  • - Lateral Partner Moves
  • - Pro bono
  • - Key Contacts

Fitzpatrick, Cella, Harper & Scinto

  • Designation: New York
  • Head Count: 137
  • Gross Revenues: $98,000,000
  • Revenue Per Lawyer: $715,000
  • Profits Per Partner: $690,000
  • Year Over Year Change: N/A

Fitzpatrick, Cella, Harper & Scinto is a New York-based law firm.  According to the National Law Journal's 2016 NLJ 350 ranking of firms based on size, Fitzpatrick, Cella, Harper & Scinto has 137 attorneys and is the 291st largest firm in the United States.  With $98,000,000 in gross revenue in 2015, the firm placed 191st on The American Lawyer's 2016 Am Law 200 ranking.  The firm has offices in CA, DC and NY.

Firm Rankings

Survey Rank Year Over Year Change Description
Am Law 100 NR N/A Gross revenue
Am Law 200 191 3 Gross revenue
NLJ 250 255 -17 Lawyer head count
The A-List NR N/A Overall excellence
Pro Bono Scorecard 103 -9 Pro-bono commitment
Diversity Scorecard 73 1 Minority head count
Midlevel Associates Survey 70 -21 Job satisfaction
Summer Associates Survey NR N/A Summer programs

In the News

Head Count Declines Outpaced Growth Among NY Firms

Christine Simmons : New York Law Journal : July 11, 2016

The largest law firms in New York showed wide disparity in attorney head count growth, and gains at some firms were outweighed by deep drops at others.

Fitzpatrick, Cella, Harper & Scinto

C. Ryan Barber : The National Law Journal : May 23, 2016

Fitzpatrick, Cella, Harper & Scinto buys a lot of toner cartridges. But many never make it into the firm's printers.

The 2016 Midsize Hot List

: The National Law Journal : May 23, 2016

The 20 firms we highlight this week have held their own, often against much larger firms, charting winning courses in high-stakes matters that led to key victories in 2015.

PTAB Is No Patent Killer, Report Finds

Lisa Shuchman : Corporate Counsel : May 03, 2016

Anecdotal reports have suggested that the U.S. Patent and Trademark Office's Patent Trial and Appeal Board has created a dire situation for patent owners, but a recently released study has found that outcomes from the PTAB are much more balanced.

Pharma Patent Battles Seeing Steep Increase

Lisa Shuchman : Corporate Counsel : April 26, 2016

The number of patent litigation filings related to new drug applications before the FDA, known as ANDA filings, increased dramatically in 2014-15.